Study 110933: Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus

Trial Profile

Study 110933: Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2017

At a glance

  • Drugs Albiglutide (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 23 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 31 Oct 2017 This trial has been discontinued in Germany (end date: 18 Oct 2017).
    • 07 Aug 2017 Planned End Date changed from 19 Feb 2018 to 9 Oct 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top